期刊文献+

胃肠胰神经内分泌肿瘤病理诊断共识与争议 被引量:12

Consensus and controversy of pathological diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms
原文传递
导出
摘要 第4版《世界卫生组织消化系统肿瘤分类》发布了2010年版胃肠胰神经内分泌肿瘤(gastroenteropancreatic neuroendocrine neoplasm,GEP-NENs)新分类。根据新分类,2011年《中国胃肠胰神经内分泌肿瘤病理学诊断共识》(下文简称《中国共识》)发表,成为首个统一中国GEP-NENs病理诊断名称、分类和分级,规范GEP-NENs病理诊断的指导性意见。随后几年有关GEP-NENs的临床研究获得了一些重要数据和发现,对GEP-NENs的分类、分级系统提出了新见解。根据近年来在GEP-NENs方面新的临床研究结果和实际工作中遇到的具体问题,2013年发表的对《中国共识》的更新,进一步强调了一些在GEP-NENs常规病理诊断时的要点,补充了不同分化程度时典型的GEP-NENs形态特点描述,介绍了增殖活性指数计数方法。针对尚存争议的分化中等的G3肿瘤,2013年更新的《中国共识》也提出了自己的观点和建议,有待于临床和病理的进一步研究证实。 Revised classification, nomenclature and grading system of gastroenteropanereatie neuroendocrine neoplas (GEP-NENs) was proposed by the fourth edition World Health Organization Classification of Tumours of the Digestive System in 2010. Chinese Consensus of Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Neoplasm (hereinafter referred to as Chinese Consensus ) was issued in 2011. It apparently contributes to unify the methods of classification, put an end of the confusion in nomenclature, standardize the grading system and predict the outcomes more accurately. Recently, new advances in GEP-NENs study put forward a new view in the classification and grading system that leading to several controversies. Consequently, an update of Chinese Consensus was published in 2013. It not only emphasized the key points of pathological diagnosis of GEP-NENs, expanded the content of morphological description and the methods of proliferation index evaluation, but also made its own suggestions aimed at the pending problem. However, the update of system needs further studies.
作者 盛伟琪
出处 《中国实用外科杂志》 CSCD 北大核心 2014年第6期493-496,共4页 Chinese Journal of Practical Surgery
关键词 胃肠胰神经内分泌肿瘤 病理诊断 gastroenteropancreatic neuroendocrine neo-plasm pathological diagnosis
  • 相关文献

参考文献15

  • 1Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the co- lon and rectum[M]//Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumours of the Digestive System.Lyon: IARC Press, 2010.
  • 2中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. 被引量:291
  • 3中国胃肠胰神经内分泌肿瘤病理诊断共识(2013版)[J].中华病理学杂志,2013,42(10):691-694. 被引量:162
  • 4Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classi- fication of neuroendocrine tumors: a review of nomenclature, grading, and staging systems [ J ].Pancreas,2010,39(6) : 707-712.
  • 5Pearse AG. The cytochemistry and ultrastructure of polypeptide hormone-producing ceils of the APUD series and the embryolog- ic, physiologic and pathologic implications of the concept [J].J Histochem Cytochem,1969,17(5) : 303-313.
  • 6Klimstra DS, Modlin IR, Adsay NV, et al.Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set [J ]. Am J Surg Pathol, 2010,34(3) : 300-313.
  • 7Adams AL, Siegal GP, Jhala NC. Solid pseudopapillary tumor of the pancreas: a review of salient clinical and pathologic features [J ].Adv Anat Pathol, 2008,15(1) : 39-45.
  • 8Papotti M, Bongiovanni M, Volante M, et al. Expression of soma- tostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors . A correlative immunohistochemi- cal and reverse-transcriptase polymerase chain reaction analysis [J ].Virchows Arch, 2002,440(5): 461-475.
  • 9Scoazec JY, Couvelard A, monges G, et al.Well-differentiated grade 3 digestive neuroendocrine tumors: myth or realty?The PRO NET study group [ J ] .J Clin Oncol, 2012,30 (suppl) :4129.
  • 10Adsay V. Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract.To count or not to count is not the question, but rather how to count[J].Am J Surg Pathol,2012, 36(12): 1743-1746.

二级参考文献14

  • 1Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 2Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 3Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 4Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 5Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 6Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 7Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 8Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.
  • 9Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000.
  • 10Rindi G,Kl(o)ppel G,Alhman H,et al.TNM staging of foregut (neuro) endocrine tumors:a consensus proposal including a grading system.Virchows Arch,2006,449(4):395-401.

共引文献427

同被引文献76

引证文献12

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部